Skip to main content

Table 8 Summary of analysis of adverse events (AEs) in all subjects

From: Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects

  Study group
Placebo (n = 30) Meratrim (n = 30)
Severity
 Mild 9 7
 Moderate 0 0
 Severe 0 0
Relationship to Test Article
 Not related 9 7
 Possible 0 0
 Definite 0 0
Body System and AEs
 Gastrointestinal   
 Acidity 0 2
 Dyspepsia 2 3
 Nausea 1 1
 Gastritis 1 1
Pain
 Headache 1 0
Dermatology
 Itching 1 0
 Rash on forearm 1 0
Neurology
 Giddiness 1 0
Circulatory
 Feet swelling 1 0
Total Number of Adverse Events Experienced During Study 9 7
Total Number of Subjects Experiencing Adverse Events: n (%) 6/30 (20 %) 5/30 (17 %)